This announcement is a separate document:
麗珠醫藥:2023年第三季度報告
LIVZON PHARMA: 2023 THIRD QUARTERLY REPORT
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.